Indian Journal of Urology Users online:438  
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size

Year : 2010  |  Volume : 26  |  Issue : 3  |  Page : 465-466

A minimally invasive non-thermal ablative modality for prostate: Histotripsy

Department of Urology, C.S.M. Medical University (Upgraded king George's Medical College), Lucknow, Uttar Pradesh, India

Date of Web Publication1-Oct-2010

Correspondence Address:
Apul Goel
Department of Urology, C.S.M. Medical University (Upgraded king George's Medical College), Lucknow, Uttar Pradesh
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions


How to cite this article:
Dwivedi AK, Sengottayan VK, Goel A. A minimally invasive non-thermal ablative modality for prostate: Histotripsy. Indian J Urol 2010;26:465-6

How to cite this URL:
Dwivedi AK, Sengottayan VK, Goel A. A minimally invasive non-thermal ablative modality for prostate: Histotripsy. Indian J Urol [serial online] 2010 [cited 2021 Dec 9];26:465-6. Available from:

Hall TL, Hempel CR, Wojno K, Xu Z, Cain CA, Roberts WW. Histotripsy of the prostate: Dose effects in a chronic canine model. Urology 2009;74:932-7.

   Summary Top

Feasibility of histotripsy for ablation of prostatic tissue has been demonstrated in canine models in a previous study. [1] The current study is a continuation of a previous study and aims to define the dose to be given to develop it as a modality to be used in clinical practice. The study was conducted on 20 canines with prostates greater than 20ml. Histotripsy of variable doses were given to all subjects (56000, 160000 and 540000 pulse) and tissue response was objectively demonstrated at various intervals. Five subjects were euthanized immediately, seven at seven days, and eight at 28 days. Chronic canine models (canines that did not euthanized immediately but followed for a week or more and examined subsequently) were catheterized with a 12F urinary catheter placed immediately after treatment and left in place for 24 to 72 hours. After euthanasia, the prostate, bladder, and adjacent rectum were surgically removed en bloc and inspected grossly and microscopically for injury. The lowest dose (56000 pulses) applied was found to produce only scattered cellular disruption and necrosis, whereas higher doses produced more significant regions of tissue effect that resulted in sufficient fractionation so that the necrosed tissue could be voided with urination. Tissue responses in chronic canine models found that the targeted volume was replaced by collapsed cavity lined by transitional cells. Tissue lesions in histotripsy were quite sharply demarcated with very little surrounding tissue injury. The doses required for parenchymal tissue and urethra were defined; it was found that higher doses are required for urethra to create similar necrotic effect as in parenchyma. The study has practical implication regarding the optimal dose of histotripsy for treatment.[2]

   Comment Top

There is a constant search for a non-invasive modality that has the benefit of rapid tissue debulking property of trans-urethral resection of prostate (TURP) and which is safe; histotripsy appears to fulfil both criteria. Almost all minimal invasive modalities developed for treatment of benign prostate hyperplasia (BPH), like trans-urethral needle ablation of prostate (TUNA), trans-urethral microwave therapy (TUMT) and high-intensity focused ultrasound (HIFU) work by heating of prostatic parenchyma which causes coagulative necrosis. Cells injured by this mechanism are gradually reabsorbed over two to three weeks. Prostatic edema due to thermal injury increases its size and poses risk of urinary retention, and so there is a need for urethral catheterization for two to four weeks. [3],[4]

Histotripsy, like HIFU, utilises the therapeutic potential of ultrasound waves. While ultrasound used in HIFU has a therapeutic effect by directly heating the tissue thereby causing coagulative necrosis, histotripsy immediately ablates tissue by liquefaction caused by the mechanical effect of highly vibrating micro bubbles created at focal region of histotripsy, causing adjacent tissue breakdown. In HIFU, energy is delivered in a continuous fashion or as long pulses (0.015 to 4 seconds) leading to energy absorption in the focal zone exceeding the ability of the tissue to dissipate heat, thus, resulting in a temperature increase causing coagulative necrosis. In contrast, ultrasound waves used in histotripsy have intermittent highly intense burst pattern with short duty cycle (per cent of time when ultrasound energy is delivered) of only 0.2% compared to 100% with HIFU. [5]

A short duty-cycle gives tissues time to dissipate heat and so minimizes heating of adjacent neurovascular bundles and sphincters. Liquefied tissue (prostate) is drained through urethra by creating a rent in the urethral wall by providing more intense energy at urethra. Histotripsy appears appealing due to rapid tissue debulking, highly accurate tissue ablation and non-thermal mode of tissue injury. To date, experience of histotripsy is limited to canine models only and no human trial has been conducted yet. This technology needs to be modified to be useful in humans, as prostate in humans is deeply seated in pelvis in comparison to canines and not amenable to be focused extra corporally through the abdomen. Canine prostate is also not equivalent to human prostate in BPH due to different stromal and glandular architecture. Further investigations and clinical trials are needed to make this highly fascinating modality clinically relevant.

   References Top

1.Lake AM, Hall TL, Kieran K, Fowlkes JB, Cain CA, Roberts WW. Histotripsy: minimally invasive technology for prostatic tissue ablation in an in vivo canine model. Urology 2008;72:682-6.  Back to cited text no. 1  [PUBMED]  [FULLTEXT]  
2.Hall TL, Hempel CR, Wojno K, Xu Z, Cain CA, Roberts WW. Histotripsy of the prostate: dose effects in a chronic canine model. Urology 2009;74:932-7.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]  
3.Yu X, Elliott SP, Wilt TJ, McBean AM. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. J Urol 2008;180:241-5.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]  
4.Dubinsky TJ, Cuevas C, Dighe MK, Kolokythas O, Hwang JH. High-intensity focused ultrasound: current potential and oncologic applications. AJR Am J Roentgenol 2008;190:191-9.  Back to cited text no. 4  [PUBMED]  [FULLTEXT]  
5.Roberts WW, Hall TL, Ives K, Wolf JS Jr, Fowlkes JB, Cain CA. Pulsed cavitational ultrasound: a noninvasive technology for controlled tissue ablation (histotripsy) in the rabbit kidney. J Urol 2006;175:734-8.  Back to cited text no. 5  [PUBMED]  [FULLTEXT]  


Print this article  Email this article
Previous article Next article


   Next article
   Previous article 
   Table of Contents
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (170 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


 Article Access Statistics
    PDF Downloaded104    
    Comments [Add]    

Recommend this journal